RushNet, Inc. (OTC: RSHN) is quickly becoming one of the OTC’s hottest stocks as a result of a number of catalysts that are in the works. RSHN has been working in the healthcare sector through its two companies, providing billing services and laboratory testing services to those in the sector. Investors are paying attention to RSHN stock since the firm wants to distribute a share dividend of the shares of its spin-off following the combination of both of its subsidiaries. Many investors are bullish that RSHN stock might jump on fresh details regarding the spin-off because the spin-off would be listed on the NASDAQ.
Ashley Sweat, who is currently the company’s chairman and CEO, acquired RSHN’s controlling interest in 2021. Since then, RSHN has made a turn into the healthcare sector by acquiring Grandeza Healthcare, a healthcare billing and consulting firm, and the diagnostics lab HeliosDX. RSHN provided a 15-month path through these acquisitions that would result in the company’s NASDAQ uplisting. Uplisting RSHN to the NASDAQ, however, was rejected by the company’s management as an option.